Mutsuo Shigemoto

514 citations
27 papers · 267 indexed · h-index 11
Topics
Helicobacter pylori-related gastroenterology studies (11 papers)Liver Disease Diagnosis and Treatment (7 papers)Gastric Cancer Management and Outcomes (5 papers)
Partner nations
JapanUnited States

In The Last Decade

Mutsuo Shigemoto

27 papers receiving 254 citations

Peers

Mutsuo Shigemoto
Comparison fields: 5 of 67
  • Surgery 99
  • Molecular Biology 81
  • Epidemiology 54
  • Pulmonary and Respiratory Medicine 49
  • Hepatology 37
Replace Matteus Krappitz with:
Matteus Krappitz Germany
Li Xiao China
Cláudia Maria Peres Italy
Cai H China
Hirosumi Oide Japan
Airong Wu China
Anna Walentinsson Sweden
Wen Feng China
Hu Zhang China
Mutsuo Shigemoto relative to Matteus Krappitz Germany Matteus Krappitz's profile →
Citations per field
00.5×1.5×1.9×
Matteus Krappitz · 1×
Citations per year

Countries citing papers authored by Mutsuo Shigemoto

Since Specialization
Citations

This map shows the geographic impact of Mutsuo Shigemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mutsuo Shigemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mutsuo Shigemoto more than expected).

Fields of papers citing papers by Mutsuo Shigemoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mutsuo Shigemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mutsuo Shigemoto. The network helps show where Mutsuo Shigemoto may publish in the future.

Co-authorship network of co-authors of Mutsuo Shigemoto

This figure shows the co-authorship network connecting the top 25 collaborators of Mutsuo Shigemoto. A scholar is included among the top collaborators of Mutsuo Shigemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mutsuo Shigemoto. Mutsuo Shigemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 8
3 2
4 19
5 13
6 12
7 29
8
Impaired blood rheology by remnant-like lipoprotein particles: studies in patients with fatty liver disease.
17
9 1
10 1
11 20
12 6
13 8
14 1
15 12
16
Effect of interferon therapy in a patient with chronic active hepatitis type C associated with interstitial pneumonia and rheumatoid arthritis: a case report.
2
17
Inhibitory effect of ursodeoxycholic acid on the progression of chronic hepatic disorders with special reference to increases in blood flow.
1
18 8
19
[Clinical studies and sputum levels of ceftriaxone once daily administration in respiratory tract infection].
1
20
Salivary immunoreactive human epidermal growth factor (IR-hEGF) in patients with peptic ulcer disease.
37

About Mutsuo Shigemoto

Mutsuo Shigemoto is a scholar working on Hepatology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 27 papers that have together received 267 indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (11 papers), Liver Disease Diagnosis and Treatment (7 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Hepatology (37 citations), Pharmacology (20 citations) and Surgery (99 citations). Mutsuo Shigemoto has collaborated with scholars based in Japan and United States. Frequent co-authors include Katsuko Yamashita, Izumi Yokoyama, Atsushi Maeda, Hiroshi Hashimoto, Hiroshi Hashimoto, Takeshi Kurihara, Eiji Ohmura, Takahiro Tsushima, KAZUO SHIZUME and Naoya Emoto. Their work appears in journals such as Gastroenterology, Biochemical and Biophysical Research Communications and Clinical Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026